Consent for Use of Stored Patient Specimens for Future Testing

Not currently recruiting at 66 trial locations
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial seeks permission to use stored samples, such as blood or tissues, for future studies, which might include genetic testing. It primarily targets individuals who are or have been part of a specific clinical trial group. Those who fit this description may be eligible to participate.

As an unphased trial, this study provides a unique opportunity to contribute to future medical advancements and potentially benefit from new insights.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores a new approach to obtaining consent for using stored patient specimens in future testing. Unlike standard practices where specimens might be used without explicit future consent, this trial emphasizes informed consent, ensuring patients are aware and agree to potential future uses of their specimens. This approach could enhance ethical standards in research and empower patients with more control over their biological samples, potentially leading to more trust and transparency in medical research.

Who Is on the Research Team?

DW

David W. Haas, MD

Principal Investigator

Vanderbilt University Medical Center

Are You a Good Fit for This Trial?

Inclusion Criteria

Parent or guardian willing to give informed consent, if applicable
Either currently participating in or have ever participated in an AACTG clinical tria

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

Consent

Participants are asked to sign the informed consent form to allow their leftover samples to be used for secondary analyses and to have a blood sample drawn for DNA archiving

Sample Collection

Collection of 14 ml blood sample for DNA archiving for use in currently unspecified genetic analyses

Follow-up

Participants are monitored for any extraordinary circumstances that may require notification of test results from secondary testing

What Are the Treatments Tested in This Trial?

Interventions

  • Consent for Use of Stored Patient Specimens for Future Testing

Find a Clinic Near You

Who Is Running the Clinical Trial?

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Lead Sponsor

Trials
103
Recruited
74,200+

AIDS Clinical Trials Group

Lead Sponsor

Trials
101
Recruited
73,600+

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborator

Trials
3,361
Recruited
5,516,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security